» Articles » PMID: 35365216

Biological Roles of RNA MC Modification and Its Implications in Cancer Immunotherapy

Overview
Journal Biomark Res
Publisher Biomed Central
Date 2022 Apr 2
PMID 35365216
Authors
Affiliations
Soon will be listed here.
Abstract

Epigenetics including DNA and RNA modifications have always been the hotspot field of life sciences in the post-genome era. Since the first mapping of N6-methyladenosine (mA) and the discovery of its widespread presence in mRNA, there are at least 160-170 RNA modifications have been discovered. These methylations occur in different RNA types, and their distribution is species-specific. 5-methylcytosine (mC) has been found in mRNA, rRNA and tRNA of representative organisms from all kinds of species. As reversible epigenetic modifications, mC modifications of RNA affect the fate of the modified RNA molecules and play important roles in various biological processes including RNA stability control, protein synthesis, and transcriptional regulation. Furthermore, accumulative evidence also implicates the role of RNA mC in tumorigenesis. Here, we review the latest progresses in the biological roles of mC modifications and how it is regulated by corresponding "writers", "readers" and "erasers" proteins, as well as the potential molecular mechanism in tumorigenesis and cancer immunotherapy.

Citing Articles

RNA Modification in Metabolism.

Liu Y, Sun Z, Gui D, Zhao Y, Xu Y MedComm (2020). 2025; 6(3):e70135.

PMID: 40066222 PMC: 11892166. DOI: 10.1002/mco2.70135.


ALKBH1 knockdown promotes the growth, migration and invasion of HTR-8/SVneo cells through regulating the m5C modification PSMD14.

Zhang C, Li J, Wang L, Yang P, Luo X Sci Rep. 2025; 15(1):7345.

PMID: 40025166 PMC: 11873043. DOI: 10.1038/s41598-025-91233-3.


Detection, molecular function and mechanisms of m5C in cancer.

Zhang L, Li Y, Li L, Yao F, Cai M, Ye D Clin Transl Med. 2025; 15(3):e70239.

PMID: 40008496 PMC: 11862898. DOI: 10.1002/ctm2.70239.


Nsun2 controls cardiac homeostasis and hypertrophic response by regulating PRKACA expression.

Jian D, Cheng X, Qi D, Wang S, Wang C, Shi Y Theranostics. 2025; 15(6):2393-2412.

PMID: 39990213 PMC: 11840729. DOI: 10.7150/thno.104441.


Identification and validation of an m5C-related lncRNA signature for predicting prognosis and immune response in clear cell renal cell carcinoma.

Ao S, Liang L, Peng L, Yang R, Chen Z, Deng T Discov Oncol. 2025; 16(1):227.

PMID: 39987537 PMC: 11847763. DOI: 10.1007/s12672-025-01987-5.


References
1.
Chen Y, Yang W, Zhao Y, Yang Y . Dynamic transcriptomic m C and its regulatory role in RNA processing. Wiley Interdiscip Rev RNA. 2021; 12(4):e1639. DOI: 10.1002/wrna.1639. View

2.
Van Haute L, Lee S, McCann B, Powell C, Bansal D, Vasiliauskaite L . NSUN2 introduces 5-methylcytosines in mammalian mitochondrial tRNAs. Nucleic Acids Res. 2019; 47(16):8720-8733. PMC: 6822013. DOI: 10.1093/nar/gkz559. View

3.
Chen X, Li A, Sun B, Yang Y, Han Y, Yuan X . 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. Nat Cell Biol. 2019; 21(8):978-990. DOI: 10.1038/s41556-019-0361-y. View

4.
Gu X, Zhou H, Chu Q, Zheng Q, Wang J, Zhu H . Uncovering the Association Between mC Regulator-Mediated Methylation Modification Patterns and Tumour Microenvironment Infiltration Characteristics in Hepatocellular Carcinoma. Front Cell Dev Biol. 2021; 9:727935. PMC: 8475949. DOI: 10.3389/fcell.2021.727935. View

5.
Kariko K, Buckstein M, Ni H, Weissman D . Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. Immunity. 2005; 23(2):165-75. DOI: 10.1016/j.immuni.2005.06.008. View